Navigation Links
New developments in reproductive medicine
Date:8/31/2009

Three out of ten women who undergo polar body diagnosis go on to have a child. The extensive technique of polar body analysis (PBA) is described by researchers in reproductive medicine at Lbeck in an article in the current edition of Deutsches rtzeblatt International, in which they present three successful cases and one failure (Dtsch Arztebl Int 2009; 106(33): 533-8).

Polar bodies are by-products of normal cell division (meiosis) of an oocytea woman's egg cellon its way to maturation. For people with monogenic diseases, which are caused by gene defects, polar body analysis can give an indication of whether the healthy version of the gene is present in the egg before fertilization takes place. Monogenic diseases, such as cystic fibrosis, are caused by an altera-tion of one gene; this makes them different from polygenic diseases, such as diabetes mellitus, for example, which are caused by a combination of defects in several genes.

In the cases of four women who were carriers of a monogenic disease, their own egg cells containing the intact version of the gene concerned were fertilized, allowed to develop to the embryonic stage, and then transferred into the womb. Three of the women had a successful pregnancy and gave birth to a healthy child. One woman failed to become pregnant, even after a further round of PBA fol-lowed by embryo transfer, and decided not to continue the treatment. These four cases are among nine couples tested using PBA at Lbeck by Georg Griesinger and his co-authors because of a known risk that the mother might transmit a monogenic disease.

In Germany PBA is an alternative to preimplantation diagnosis (PID), which depending on the result can lead to termination of pregnancy with all the associated psychological and physical stresses. The disadvantages of PBA are: hereditary diseases transmitted through the father cannot be diagnosed, and in the case of autosomal recessive diseases egg cells that would have resulted in the birth of healthy heterozygous carriers are discarded. In Germany, PBA for monogenic diseases is at present performed at only two centers, in Lbeck and Regensburg.


'/>"/>

Contact: E. Bartholomaeus
49-223-470-11133
Deutsches Aerzteblatt International
Source:Eurekalert

Related biology news :

1. Bovine genome provides clues to possible new developments
2. AACR annual meeting showcases developments in understanding and targeting cancers
3. Progress Against Malaria: Developments on the Horizon
4. 2 reproductive factors are important predictors of death from ovarian cancer
5. Plastics chemical retards growth, function of adult reproductive cells
6. Environmental cues control reproductive timing and longevity, University of Minnesota study shows
7. Stress puts double whammy on reproductive system, fertility
8. Recruitment of reproductive features into other cell types may underlie extended lifespan in animals
9. The importance of being helpful -- Cooperative cichlids boost their own reproductive success
10. Study: Health undervalued in reproductive rights debate
11. NIH funds research center for womens reproductive health at Einstein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... January 19, 2017 According to a new report published ... 2014 - 2022," the global biometric sensor market is expected to garner $1.5 ... In 2015, Asia-Pacific dominated the global market and contributed ... Continue Reading ... ...
(Date:1/18/2017)... MINNETONKA, Minn. , Jan. 18, 2017 /PRNewswire/ ... eClinical technology company that supports the entire spectrum ... 2016 has been another record-breaking year for the ... and market interest in MedNet,s eClinical products and ... to the tremendous marketplace success of ...
(Date:1/12/2017)... 12, 2017  New research undertaken by Fit Small ... future.  1,000 participants were simply asked which office technology had ... may consider standard issue.  Insights on what will ... gathered from futurists and industry leaders including Penelope Trunk ... .  Some of these findings ...
Breaking Biology News(10 mins):
(Date:1/24/2017)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... today announced positive efficacy results from the company,s ... additional motor function improvement at 6-months and 9-months ... AIS-A patients with complete cervical spinal cord injuries ... function is critically important to patients with complete ...
(Date:1/24/2017)... USA & Geneva, Switerland (PRWEB) , ... January ... ... to announce the first commercially available malaria Plasmodium falciparum culture panels with standard ... falciparum culture panels, which are available in a range of concentrations from six ...
(Date:1/24/2017)... ... January 23, 2017 , ... Oklahoma City based Sigma Blood ... for the firm’s PERFEQTA software and legacy product QC Manager 2.0. , Sigma ... team at CJBC and thrilled that they have decided to implement PERFEQTA and QC ...
(Date:1/24/2017)... - BioAmber Inc. (NYSE: BIOA ) today announced ... Rodman & Renshaw, a unit of H.C. Wainwright ... representative of several underwriters, under which the underwriters have ... minimum of 2,105,264 shares of common stock of the ... 1,052,632 shares of common stock of the Company with ...
Breaking Biology Technology: